Lesson

References – RNP 4.05

References

  1. Center for Disease Control and Prevention. Adult Obesity Facts. 2018; https://www.cdc.gov/obesity/data/adult.html. Accessed June 28, 2018.
  2. Center for Disease Control and Prevention. Defining Adult Overweight and Obesity. 2018; https://www.cdc.gov/obesity/adult/defining.html. Accessed June 28, 2018.
  3. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.
  4. Vallis M. Quality of life and psychological well-being in obesity management: improving the odds of success by managing distress. Int J Clin Pract. 2016;70(3):196-205.
  5. Crowson CS, Matteson EL, Davis JM, 3rd, Gabriel SE. Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013;65(1):71-77.
  6. Qin B, Yang M, Fu H, et al. Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis. Arthritis Res Ther. 2015;17:86.
  7. Schulman E, Bartlett SJ, Schieir O, et al; CATCH Investigators. Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study. Arthritis Care Res (Hoboken). 2018;70(8):1185-1191.
  8. Statistics Canada. Table 13-10-0096- 20 Body mass index, overweight or obese, self-reported, adult, age groups (18 years and older). Available at www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310009620. Accessed June 28, 2018.
  9. Liu Y, Hazlewood GS, Kaplan GG, Eksteen B, Barnabe C. Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken). 2017;69(2):157-165.
  10. Wolfe F, Michaud K. Effect of body mass index on mortality and clinical status in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012;64(10):1471-1479.
  11. Ayhan FF, Ataman S, Rezvani A, et al. Obesity Associated With Active, but Preserved Joints in Rheumatoid Arthritis: Results From our National Registry. Arch Rheumatol. 2016;31(3):272-280.
  12. George MD, Baker JF. The Obesity Epidemic and Consequences for Rheumatoid Arthritis Care. Curr Rheumatol Rep. 2016;18(1):6.
  13. Abella V, Scotece M, Conde J, et al. Adipokines, metabolic syndrome and rheumatic diseases. J Immunol Res. 2014;2014:343746.
  14. Daien CI, Sellam J. Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response. RMD Open. 2015;1(1):e000012.
  15. Singh S, Facciorusso A, Singh AG, et al. Obesity and response to anti-tumor necrosis factor-alpha agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis. PLoS One. 2018;13(5):e0195123.
  16. Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis. 2007;66(10):1316-1321.
  17. Kreps DJ, Halperin F, Desai SP, et al. Association of weight loss with improved disease activity in patients with rheumatoid arthritis: A retrospective analysis using electronic medical record data. Int J Clin Rheumtol. 2018;13(1):1-10.
  18. Engelhart M, Kondrup J, Hoie L, Andsersen V, Kristensen J, et al. Weight reduction in obese patients with rheumatoid arthritis, with preservation of body cell mass and improvement of physical fitness. Clin Exp Rheumatol. 1996;14(3):289-293.
  19. Felix HC, West DS. Effectiveness of weight loss interventions for obese older adults. Am J Health Promot. 2013;27(3):191-199.
  20. Kritchevsky SB, Beavers KM, Miller ME, et al. Intentional weight loss and all-cause mortality: a meta-analysis of randomized clinical trials. PLoS One. 2015;10(3):e0121993.
  21. Okifuji A, Hare BD. The association between chronic pain and obesity. J Pain Res. 2015;8:399-408.
  22. Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev. 2014;13(9):981-1000.
  23. Scrivo R, Vasile M, Müller-Ladner U, Neumann E, Valesini G. Rheumatic diseases and obesity: adipocytokines as potential comorbidity biomarkers for cardiovascular diseases. Mediators Inflamm. 2013;2013:808125.
  24. Omenetti S, Pizarro TT. The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome. Front Immunol. 2015;6:639.
  25. Stone AA, Broderick JE. Obesity and pain are associated in the United States. Obesity (Silver Spring). 2012;20(7):1491-1495.
  26. Garcia-Poma A, Segami MI, Mora CS, et al. Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis. Clin Rheumatol. 2007;26(11):1831-1835.
  27. Heimans L, van den Broek M, le Cessie S, et al. Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients. Arthritis Care Res (Hoboken). 2013;65(8):1235-1242.
  28. Vidal C, Barnetche T, \Morel J, Combe B, D’aien C. Association of Body Mass Index Categories with Disease Activity and Radiographic Joint Damage in Rheumatoid Arthritis: A Systematic Review and Meta-analysis. J Rheumatol. 2015;42(12):2261-2269.
  29. George MD, Giles JT, Katz PP, et al. Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2017;69(12):1789-1798.
  30. Obesity Associated With Higher Degree of Synovitis in Rheumatoid Arthritis Patients [press release]. American College of Rheumatology Nov. 04, 2017.
  31. American Diabetes Association. Standards of Medical Care in Diabetes-2018 Abridged for Primary Care Providers. Clin Diabetes. 2018;36(1):14-37.
  32. Baker JF, Sauer BC, Cannon GW, et al. Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis. Arthritis Rheumatol. 2016;68(8):1818-1827.
  33. Marouen S, Barnetche T, Combe B, Morel J, D’aien C. TNF inhibitors increase fat mass in inflammatory rheumatic disease: a systematic review with meta-analysis. Clin Exp Rheumatol. 2017;35(2):337-343.
  34. Tournadre A, Pereira B, Dutheil F, et al. Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis. J Cachexia Sarcopenia Muscle. 2017;8(4):639-646.
  35. Sparks JA, Halperin F, Karlson JC, Karlson EW, Bermas BL. Impact of Bariatric Surgery on Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2015;67(12):1619-1626.
  36. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. Circulation. 2014;129(25 suppl 2):S102-S138.
  37. Davis B, O’berman A, Blaufox D, Wassertheil-Smoller s, Hawkins M, et al. Effect of antihypertensive on weight loss. Hypertension. 1992;19(4):393-399.
  38. Sandberg ME, Bengtsson C, Kallberg H, et al. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis. Ann Rheum Dis. 2014;73(11):2029-2033.
  39. Gremese E, Carletto A, Padovan M, et al. Obesity and reduction of the response rate to anti-tumor necrosis factor alpha in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res (Hoboken). 2013;65(1):94-100.
  40. Shan J, Zhang J. Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis. Joint Bone Spine. 2018 Apr 7. [Epub ahead of print].
  41. Gremese E, Tolusso B, Gigante MR, Ferraccioli G. Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases). Front Immunol. 2014;5:576.
  42. Strohl WR. Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters. BioDrugs. 2015;29(4):215-239.
  43. Porter C, Armstrong-Fisher S, Kopotsha T, et al. Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer. J Reprod Immunol. 2016;116:7-12.
  44. Escalante A, Haas RW, del Rincón I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med. 2005;165(14):1624-9.
  45. Sparks JA, Chang SC, Nguyen US, et al. Weight Change During the Early Rheumatoid Arthritis Period and Risk of Subsequent Mortality in Women With Rheumatoid Arthritis and Matched Comparators. Arthritis Rheumatol. 2018;70(1):18-29.
  46. Baker JF, Billig E, Michaud K, et al. Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis. Arthritis Rheumatol. 2015;67(7):1711-1717.
  47. Johns DJ, Hartmann-Boyce J, Jebb SA, Aveyard P, Behavioural Weight Management Review G. Diet or exercise interventions vs combined behavioral weight management programs: a systematic review and meta-analysis of direct comparisons. J Acad Nutr Diet. 2014;114(10):1557-1568.
  48. Garvey TQ, Mechanick JI, E B, Garber A, Hurley DL, et al. American Association of Clinical Endocrinologists and American College of Endocrinology COmprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice. 2016;2(suppl 3):1-203.
  49. Smolen JS, Landewe R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960-977.
  50. Singh JA, Saag KG, Bridges SL, Jr., et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2016;68(1):1-25.
  51. de Souza RJ, Bray GA, Carey VJ, et al. Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. Am J Clin Nutr. 2012;95(3):614-625.
  52. Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009;360(9):859.
  53. Kenney K. Nutrition Guidelines for People With Rheumatoid Arthritis. Available at www.arthritis.org/living-witharthritis/arthritis-diet/anti-inflammatory/rheumatoid-arthritis-diet. Accessed June 28, 2018.
  54. Hu Y, Costenbader KH, Gao X, Hu FB, Karlson EW, Lu B. Mediterranean diet and incidence of rheumatoid arthritis in women. Arthritis Care Res (Hoboken). 2015;67(5):597-606.
  55. Skoldstam L, Hagfor L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62:208-214.
  56. Piva SR, Almeida GJ, Wasko MC. Association of physical function and physical activity in women with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2010;62(8):1144-1151.
  57. Geenen R, Overman CL, Christensen R, et al. EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018;77(6):797-807.
  58. Hernandez-Hernandez MV, Diaz-Gonzalez F. Role of physical activity in the management and assessment of rheumatoid arthritis patients. Reumatol Clin. 2017;13(4):214-220.
  59. Jacquemin C, Servy H, Molto A, et al. Physical Activity Assessment Using an Activity Tracker in Patients with Rheumatoid Arthritis and Axial Spondyloarthritis: Prospective Observational Study. JMIR Mhealth Uhealth. 2018;6(1):e1.
  60. Salliot C, van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis. 2009;68(7):1100-1104.
  61. American Society for Metabolic and Bariatric Surgery. Estimate of Bariatric Surgery Numbers, 2011-2016. Available at asmbs.org/resources/estimate-of-bariatric-surgery-numbers. Accessed June 28, 2018.
  62. Lespessailles E, Toumi H. Vitamin D alteration associated with obesity and bariatric surgery. Exp Biol Med (Maywood). 2017;242(10):1086-1094.
  63. Miller GD, Nicklas BJ, Fernandez A. Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2011;7(5):618-624.
  64. Hassan S, Hassan C. Bariatric Surgery: What the Rheumatologist Needs to Know. J Rheumatol. 2016;43(6):1001-1007.
  65. Abate KS, Buttaro TM. Pharmacotherapeutics for bariatric surgery patients in the primary care setting: An overview for nurse practitioners. Clinical Nursing Studies. 2014;3(1).
  66. Bristo-Myers Squibb. Prescribing Information. ORENCIA (abatacept) for injection and subcutaneous use. Revised 06/2017.
  67. Genentech. Prescribing Information. ACTEMRA® (tocilizumab) injection, for intravenous or subcutaneous use. Revised 03/2018.
  68. Janssen Biotech. Prescribing Information. REMICADE (infliximab) Lyophilized Concentrate for Injection, for Intravenous Use. Revised 10/2017.
  69. Felix EL, Kettelle J, Mobley E, Swartz D. Perforated marginal ulcers after laparoscopic gastric bypass. Surg Endosc. 2008;22(10):2128-2132.
  70. Boggs W. Obesity Associated with Increased Inflammatory Markers in Rheumatoid Arthritis. The Rheumatologist. Available at www.the-rheumatologist.org/?s=Obesity+Associated+with+Increased+Inflammatory+Markers+in+Rheumatoid+Arthritis. Accessed June 28, 2018.
  71. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient–2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis. 2013;9(2):159-191.